Ross Lyda

Ross Lyda is currently serving as the Associate Director of US Product Strategy at Incyte, focusing on Rare GI Oncology-Biomarkers and Hematology/Oncology since December 2023. Prior to this role, Ross worked at Theratechnologies Inc. as a Thought Leader Liaison, where leadership skills were utilized to build strong relationships with key thought leaders and collaborate with various departments to implement national strategies. Ross's extensive experience at Genentech spanned nearly two decades, holding roles such as Biomarker Testing Account Executive and Senior Oncology Representative in both Hematology and Immunotherapy. Additionally, Ross began a career as a Resistance Specialist at Virologic Labs. Educational qualifications were obtained from the College of Charleston.